Evaluating Xihuang Pill to Improve the Efficacy of Neoadjuvant Chemotherapy for Breast Cancer
Evaluate the effectiveness of Xihuang Pill in improving the efficacy of neoadjuvant chemotherapy for breast cancer
Breast Cancer|Chemotherapy Effect
DRUG: Epirubicin, Cyclophosphamide, Xihuang Pill, Docetaxel|DRUG: Epirubicin, Cyclophosphamide, Docetaxel
Pathological complete response (pCR), Pathological complete response, six months
1. To evaluate the safety and effectiveness of Xihuang Pill in improving the efficacy of neoadjuvant chemotherapy for breast cancer under the condition of widespread use.
2. To provide data support for improving the efficacy of neoadjuvant chemotherapy for clinical breast cancer patients.